177 related articles for article (PubMed ID: 8044770)
1. Antiproliferative effects of enediynes on AIDS-derived Kaposi's sarcoma cells.
Corbeil J; Richman DD; Wrasidlo W; Nicolaou KC; Looney DJ
Cancer Res; 1994 Aug; 54(16):4270-3. PubMed ID: 8044770
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of AIDS-Kaposi's sarcoma cell proliferation following retinoic acid receptor activation.
Guo WX; Gill PS; Antakly T
Cancer Res; 1995 Feb; 55(4):823-9. PubMed ID: 7850796
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture.
Kaaya EE; Parravicini C; Ordonez C; Gendelman R; Berti E; Gallo RC; Biberfeld P
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Nov; 10(3):295-305. PubMed ID: 7552491
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Kaposi's sarcoma in vivo by fenretinide.
Ferrari N; Morini M; Pfeffer U; Minghelli S; Noonan DM; Albini A
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6020-9. PubMed ID: 14676128
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-4 receptor expression in vivo on human AIDS-related Kaposi's sarcoma.
Varricchio F; Husain SR; Leland P; Gill P; Puri RK
Oncol Res; 1997; 9(9):495-503. PubMed ID: 9495455
[TBL] [Abstract][Full Text] [Related]
7. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B
J Immunol; 1999 May; 162(9):5616-23. PubMed ID: 10228045
[TBL] [Abstract][Full Text] [Related]
8. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
9. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.
Guenova E; Metzler G; Hoetzenecker W; Berneburg M; Rocken M
Arch Dermatol; 2008 May; 144(5):692-3. PubMed ID: 18490609
[No Abstract] [Full Text] [Related]
10. Influence of foscarnet on HIV-associated Kaposi's sarcoma derived cell lines.
Willers CP; Reimann G; Mertins L; Brockmeyer NH
Eur J Med Res; 1999 Dec; 4(12):514-6. PubMed ID: 10611055
[TBL] [Abstract][Full Text] [Related]
11. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
12. Resistance of AIDS-associated Kaposi's sarcoma cells to Fas-mediated apoptosis.
Mori S; Murakami-Mori K; Jewett A; Nakamura S; Bonavida B
Cancer Res; 1996 Apr; 56(8):1874-9. PubMed ID: 8620507
[TBL] [Abstract][Full Text] [Related]
13. Controlled-release of doxorubicin from poly(lactide-co-glycolide) microspheres significantly enhances cytotoxicity against cultured AIDS-related Kaposi's sarcoma cells.
Mallery SR; Pei P; Kang J; Ness GM; Ortiz R; Touhalisky JE; Schwendeman SP
Anticancer Res; 2000; 20(5A):2817-25. PubMed ID: 11062689
[TBL] [Abstract][Full Text] [Related]
14. Correlation of oncostatin M secretion by human retrovirus-infected cells with potent growth stimulation of cultured spindle cells from AIDS-Kaposi's sarcoma.
Radka SF; Nakamura S; Sakurada S; Salahuddin SZ
J Immunol; 1993 Jun; 150(11):5195-201. PubMed ID: 8098726
[TBL] [Abstract][Full Text] [Related]
15. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
18. Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicin.
Castiñeiras I; Almagro M; Rodríguez-Lozano J; Fernández-Jorge B; Paradela S; Pozo JD; Fonseca E
J Dermatolog Treat; 2006; 17(6):377-80. PubMed ID: 17853313
[TBL] [Abstract][Full Text] [Related]
19. Rapidly eruptive, treatment-resistant, nodular Kaposi's sarcoma in an acquired immunodeficiency syndrome (AIDS) patient on highly active antiretroviral therapy.
Chang CA; Sanchez MR; Karen JK; Rosenman KS; Prystowsky SD
Int J Dermatol; 2009 Feb; 48(2):173-4. PubMed ID: 19200196
[No Abstract] [Full Text] [Related]
20. KS treatment inches forward.
Vazquez E
Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
